Orlicka-Płocka, M.; Fedoruk-Wyszomirska, A.; Gurda-Woźna, D.; Pawelczak, P.; Krawczyk, P.; Giel-Pietraszuk, M.; Framski, G.; Ostrowski, T.; Wyszko, E.
Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants 2021, 10, 950.
https://doi.org/10.3390/antiox10060950
AMA Style
Orlicka-Płocka M, Fedoruk-Wyszomirska A, Gurda-Woźna D, Pawelczak P, Krawczyk P, Giel-Pietraszuk M, Framski G, Ostrowski T, Wyszko E.
Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants. 2021; 10(6):950.
https://doi.org/10.3390/antiox10060950
Chicago/Turabian Style
Orlicka-Płocka, Marta, Agnieszka Fedoruk-Wyszomirska, Dorota Gurda-Woźna, Paweł Pawelczak, Patrycja Krawczyk, Małgorzata Giel-Pietraszuk, Grzegorz Framski, Tomasz Ostrowski, and Eliza Wyszko.
2021. "Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives" Antioxidants 10, no. 6: 950.
https://doi.org/10.3390/antiox10060950
APA Style
Orlicka-Płocka, M., Fedoruk-Wyszomirska, A., Gurda-Woźna, D., Pawelczak, P., Krawczyk, P., Giel-Pietraszuk, M., Framski, G., Ostrowski, T., & Wyszko, E.
(2021). Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives. Antioxidants, 10(6), 950.
https://doi.org/10.3390/antiox10060950
